We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App





Discovery of Endogenous Protein That Prevents Coronavirus from Fusing with Host Cells Could Help Stop COVID-19

By HospiMedica International staff writers
Posted on 03 Aug 2020
Print article
Illustration
Illustration
An international team of researchers has demonstrated that a protein produced by the human immune system can strongly inhibit coronaviruses, including SARS-CoV-2, thus raising hopes of new therapeutic approaches for the treatment of COVID-19.

An international team comprising researchers from the University of Bern (Bern, Switzerland), the Swiss Federal Office for Food Safety and Animal Health (Köniz, Switzerland), and the Ruhr-University Bochum (RUB Bochum, Germany) successfully showed that the so-called LY6E-Protein prevents coronaviruses from causing an infection.

The LY6E protein plays a role in various diseases. The researchers discovered that the protein enhances the infectivity of influenza viruses. In contrast, coronaviruses are inhibited by LY6E. In their effort to search for genes that prevent coronavirus infections, the researchers attempted to identify proteins in the human body that inhibit the spread of coronaviruses by carrying out genetic screening of several hundred so-called interferon-stimulated genes (ISGs). Among other things, ISGs produce antiviral proteins and protect against pathogens. The protein LY6E showed the strongest inhibitory effect on all coronaviruses tested, including the pathogens causing SARS and MERS as well as SARS-CoV-2 which causes COVID-19. Tests with different cell cultures showed that LY6E affects the ability of the virus to fuse with the host cells. If the virus is unable to fuse with these cells, then it cannot cause infection.

"This finding might lead to the development of new therapeutic approaches against coronaviruses," said Professor Stephanie Pfänder from the Department for Molecular and Medical Virology at RUB, co-lead author of the study.

"We wanted to find out which factors prevent corona viruses from spreading from animals to humans," said corresponding author Prof. Volker Thiel from the IVI. "Now we have succeeded in finding the needle in the haystack, so to speak. Our study provides new insights into how important these antiviral genes are for the control of viral infection and for an adequate immune response against the virus."

Related Links:
University of Bern
Swiss Federal Office for Food Safety and Animal Health
Ruhr-University Bochum


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Hysteroscopic Fluid Management System
HysteroFlow/HysteroBalance II

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Surgical Techniques

view channel
Image: NTT and Olympus have begun the world\'s first joint demonstration experiment of a cloud endoscopy system (Photo courtesy of Olympus)

Cloud Endoscopy System Enables Real-Time Image Processing on the Cloud

Endoscopes, which are flexible tubes inserted into the body's natural openings for internal examination and biopsy collection, are becoming increasingly vital in medical diagnostics. Their minimal invasiveness... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.